SOME ANTHROPOMETRIC AND BIOCHEMICAL PARAMETERS AS POTENTIAL PREDICTORS FOR TYPE 2 DIABETES IN PATIENTS IN MONTENEGRO

58. KONGRES ANTROPOLOŠKOG DRUŠTVA SRBIJE (ADS 2025), [pp. 85-94]

AUTHOR(S) / АУТОР(И): Anđelka Šćepanović  

Download Full Pdf   

DOI: 10.46793/ADS25.85S

ABSTRACT / САЖЕТАК:

Anthropometric parameters, which include body measurements such as body mass, height, waist circumference, skinfolds, body mass index (BMI), and other measures, play a crucial role in biomedical research, including research on type 2 diabetes. The application of anthropometric measurements in biomedical studies helps to better understand the pathophysiological mechanisms of type 2 diabetes and other diseases. For example, studies have shown that high BMI and abdominal obesity can increase the production of pro-inflammatory cytokines and free fatty acids, contributing to insulin resistance. Additionally, specific measurements such as waist circumference can indicate specific types of fat (visceral or subcutaneous) that have different effects on metabolism. Anthropometric parameters, especially when combined with certain biochemical markers, can also have predictive value in specific populations, such as individuals with a family history of diabetes, older adults, or ethnic groups at higher risk for type 2 diabetes. The use of these parameters can enable early identification of individuals at increased risk and the implementation of preventive measures before the disease becomes clinically manifest. Therefore, in epidemiological studies, anthropometric parameters are essential for analyzing the distribution and prevalence of type 2 diabetes in different populations. With these measurements, researchers can compare disease frequency in groups with different anthropometric characteristics and analyze potential risk factors, which can assist in shaping public health strategies for diabetes prevention.

KEYWORDS / КЉУЧНЕ РЕЧИ:

anthropometric parameters, biochemical parameters, predictors of type 2 diabetes

REFERENCES / ЛИТЕРАТУРА:

  • Adukauskienė, D., Čiginskienė, A., Adukauskaitė, A., Pentiokinienė, D., Šlapikas, R., & Čeponienė, I. (2016). Clinical relevance of high sensitivity C-reactive protein in cardiology. Medicina (Kaunas), 52, 1-10.
  • American Diabetes Association. (2016). Erratum. Classification and diagnosis of diabetes. Sec 2. In Standards of medical care in diabetes‑2016. Diabetes Care, 39(Suppl 1), S13-S22. https://doi.org/10.2337/dc16-S013
  • Andersson, C., Lvass, A., Larson, M. G., Robins, S. J., & Vasan, R. S. (2015). Low density lipoprotein cholesterol concentrations and risk of incident diabetes: Epidemiological and genetic insights from the Framingham heart study. Diabetologia, 58, 2774-2780.
  • Besseling, J., Kastelein, J. J., Defesche, J. C., Huën, B. A., & Hovingh, G. K. (2015). Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus. JAMA, 313, 1029-1036.
  • Chandra Selvi, E., Pavithra, N., & Saikumar, P. (2016). Skin fold thickness in diabetes mellitus: A simple anthropometric measurement may bare the different aspects of adipose tissue. IOSR Journal of Dental and Medical Sciences, 15(11), 7-11.
  • Chogtu, B., Magazine, R., & Bairy, K. L. (2015). Statin use and risk of diabetes mellitus. World J Diabetes, 6, 352-357.
  • Coleman, R. L., Stevens, R. J., Retnakaran, R., & Holman, R. R. (2007). Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes. Diabetes Care, 30, 1292-1293.
  • Dagan, S. S., Segev, S., Novikov, I., & Dankner, R. (2013). Waist circumference vs body mass index in association with cardiorespiratory fitness in healthy men and women: A cross-sectional analysis of 403 subjects. Nutr J, 12, 12.
  • Despres, J. P., & Lemieux, I. (2006). Abdominal obesity and metabolic syndrome. Nature, 444, 881-887.
  • Devulapally, Y., Negi, D. S., & Pasula, K. B. (2017). Comparative study of anthropometric parameters in diabetic and non-diabetic human beings. Natl J Physiol Pharm Pharmacol, 7(9), 983-989.
  • Ellulu, M. S., Patimah, I., Khaza’ai, H., Rahmat, A., & Abed, Y. (2017). Obesity and inflammation: The linking mechanism and the complications. Arch Med Sci, 13(4), 851-863.
  • Gupta, A. K., Dahlof, B., Dobson, J., Sever, P. S., Wedel, H., Poulter, N. R., et al. (2008). Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial – Blood Pressure Lowering Arm and the relative influence of antihypertensive medication. Diabetes Care, 31, 982-988.
  • Halcox, J. P., Roy, C., Tubach, F., et al. (2014). C-reactive protein levels in patients at cardiovascular risk: The EURIKA study. BMC Cardiovasc Disord, 14, 25.
  • Henninger, A. M., Eliasson, B., Jenndahl, L. E., & Hammarstedt, A. (2014). Adipocyte hypertrophy, inflammation and fibrosis characterize subcutaneous adipose tissue of healthy, non-obese subjects predisposed to type 2 diabetes. PLoS One, 9, e260.
  • Hou, X., Lu, J., Weng, J., et al. (2013). Impact of waist circumference and body mass index on risk of cardiometabolic disorder and cardiovascular disease in Chinese adults: A national diabetes and metabolic disorders survey. PLoS One, 8(3), e57319.
  • Ikeda, F., Doi, Y., Ninomiya, T., Hirakawa, Y., Mukai, N., Hata, J., et al. (2013). Haemoglobin A1c even within non-diabetic level is a predictor of cardiovascular disease in a general Japanese population: The Hisayama study. Cardiovasc Diabetol, 12, 164.
  • Jensen, M. (2006). Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model. Obesity, 14(1), 20S-24S.
  • Karam, C., Beauchet, A., Czernichow, S., et al. (2015). Trends in cardiovascular disease risk factor prevalence and estimated 10-year cardiovascular risk scores in a large untreated French urban population: The CARVAR 92 Study. PLoS ONE, 10, e0124817.
  • Karastergiou, K., Smith, R. S., Greenberg, S. A., & Fried, K. S. (2012). Sex differences in human adipose tissues – the biology of pear shape. Biol Sex Diff, 3, 13.
  • Klisic, A., Kavaric, N., Simic, T. P., Djukic, T. I., Maksimovic, M. Z., & Matic, M. G. (2014). Association between C-reactive protein, anthropometric and lipid parameters among healthy normal weight and overweight postmenopausal women in Montenegro. Lab Med, 45, 12-16.
  • Klisic, A., Kavaric, N., Jovanovic, M., Zvrko, E., Skerovic, V., Scepanovic, A., Medin, D., Ninic, A. (2017). Association between unfavorable lipid profile and glycemic control in patients with type 2 diabetes mellitus. J Res Med Sci, 22, 122.
  • Klisic, A., Kavaric, N., Stanisic, V., Vujcic, S., Spasojevic-Kalimanovska, V., Ninic, A., & Kotur-Stevuljevic, J. (2020). Endocan and a novel score for dyslipidemia, oxidative stress and inflammation (DOI score) are independently correlated with glycated hemoglobin (HbA1c) in patients with prediabetes and type 2 diabetes. Arch Med Sci, 16, 42-50.
  • Maitra, A., & Abbas, A. K. (2005). Endocrine system. In V. Kumar, N. Fausto, & A. K. Abbas (Eds.), Robbins and Cotran Pathologic basis of disease (7th ed., pp. 1156-1226). Philadelphia, Saunders.
  • McEwan, P., Williams, J. E., Griffiths, J. D., et al. (2004). Evaluating the performance of the Framingham risk equations in a population with diabetes. Diabet Med, 21, 318-323.
  • Oda, E. (2012). Metabolic syndrome: Its history, mechanisms, and limitations. Acta Diabetologica, 49(2), 89-95.
  • Özdirenç, M., Biberoğub, S., & Özcana, A. (2003). Evaluation of physical fitness in patients with Type 2 diabetes mellitus. Elsevier Science Ireland Ltd., 60(3), 171–176.
  • Papaetis, G. S., Papakyriakou, P., & Panagiotou, T. N. (2015). Central obesity, type 2 diabetes and insulin: Exploring a pathway full of thorns. Arch Med Sci, 11, 463-482.
  • Salazar, J., Martínez, M. S., Chávez, M., et al. (2014). C-reactive protein: Clinical and epidemiological perspectives. Cardiol Res Pract, 2014, 605810.
  • Sarr, O., Strohm, R. J., MacDonald, T. L., Gaudio, N., Reed, J. K., Foute-Nelong, J., Dyck, D. J., & Mutch, D. M. (2017). Subcutaneous and visceral adipose tissue secretions from extremely obese men and women both acutely suppress muscle insulin signaling. Int. J. Mol. Sci., 18(5), 959.
  • Scepanovic, A., Medin, D., Vujovic, S., Kavaric, N., & Klisic, A. (2019). Anthropometric and metabolic parameters in relation to high sensitivity C-reactive protein in Montenegrin population with type 2 diabetes. Progress in Nutrition, 21(2), 406-412.
  • Scepanovic, A., Vujovic, S., & Medin, D. (2019). Upper body subcutaneous adipose as a potential predictor for type 2 diabetes mellitus. Progress in Nutrition, 21(3), 591-597.
  • Vargas-Uricoechea, H., & Cáceres-Acosta, M. F. (2018). Control of blood pressure and cardiovascular outcomes in type 2 diabetes. Open Med (Wars), 13, 304-323.
  • World Health Organization. (2016). Global report on diabetes.